Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ambra Paolini

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
International Journal of Molecular Sciences|December 1, 2020
<i>NPM1</i>-Mutated Myeloid Neoplasms with <20% Blasts: A Really Distinct Clinico-Pathologic Entity?Fabio Forghieri, Vincenzo Nasillo, Ambra Paolini, et al.
Scientific Reports|June 17, 2021
Monocyte Distribution Width (MDW) as novel inflammatory marker with prognostic significance in COVID-19 patientsGiovanni Riva, Sara Castellano, Vincenzo Nasillo, et al.
Cells|March 25, 2022
BTK Inhibitors Impair Platelet-Mediated Antifungal ActivityVincenzo Nasillo, Ivana Lagreca, Daniela Vallerini, et al.
British Journal of Haematology|October 19, 2013
Long-term molecular remission with persistence of BCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALLGiovanni Riva, Mario Luppi, Ivana Lagreca, et al.
Clinical Case Reports|December 17, 2016
All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with <i>NPM1</i>-mutated AML unfit for intensive chemotherapy and review of the literatureFabio Forghieri, Sara Bigliardi, Chiara Quadrelli, et al.
Blood|September 21, 2011
Mucorales-specific T cells emerge in the course of invasive mucormycosis and may be used as a surrogate diagnostic marker in high-risk patientsLeonardo Potenza, Daniela Vallerini, Patrizia Barozzi, et al.
Medical Mycology|December 27, 2015
The bone marrow represents an enrichment site of specific T lymphocytes against filamentous fungiDaniela Vallerini, Giovanni Riva, Patrizia Barozzi, et al.
International Journal of Molecular Sciences|March 6, 2021
Inflammatory Microenvironment and Specific T Cells in Myeloproliferative Neoplasms: Immunopathogenesis and Novel ImmunotherapiesVincenzo Nasillo, Giovanni Riva, Ambra Paolini, et al.
International Journal of Molecular Sciences|September 10, 2021
Neoantigen-Specific T-Cell Immune Responses: The Paradigm of NPM1-Mutated Acute Myeloid LeukemiaFabio Forghieri, Giovanni Riva, Ivana Lagreca, et al.
Blood|December 9, 2016
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitorsPatrizia Comoli, Sabrina Basso, Giovanni Riva, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
International Journal of Molecular Sciences|December 1, 2020
<i>NPM1</i>-Mutated Myeloid Neoplasms with <20% Blasts: A Really Distinct Clinico-Pathologic Entity?Fabio Forghieri, Vincenzo Nasillo, Ambra Paolini, et al.
Scientific Reports|June 17, 2021
Monocyte Distribution Width (MDW) as novel inflammatory marker with prognostic significance in COVID-19 patientsGiovanni Riva, Sara Castellano, Vincenzo Nasillo, et al.
Cells|March 25, 2022
BTK Inhibitors Impair Platelet-Mediated Antifungal ActivityVincenzo Nasillo, Ivana Lagreca, Daniela Vallerini, et al.
British Journal of Haematology|October 19, 2013
Long-term molecular remission with persistence of BCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALLGiovanni Riva, Mario Luppi, Ivana Lagreca, et al.
Clinical Case Reports|December 17, 2016
All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with <i>NPM1</i>-mutated AML unfit for intensive chemotherapy and review of the literatureFabio Forghieri, Sara Bigliardi, Chiara Quadrelli, et al.
Blood|September 21, 2011
Mucorales-specific T cells emerge in the course of invasive mucormycosis and may be used as a surrogate diagnostic marker in high-risk patientsLeonardo Potenza, Daniela Vallerini, Patrizia Barozzi, et al.
Medical Mycology|December 27, 2015
The bone marrow represents an enrichment site of specific T lymphocytes against filamentous fungiDaniela Vallerini, Giovanni Riva, Patrizia Barozzi, et al.
International Journal of Molecular Sciences|March 6, 2021
Inflammatory Microenvironment and Specific T Cells in Myeloproliferative Neoplasms: Immunopathogenesis and Novel ImmunotherapiesVincenzo Nasillo, Giovanni Riva, Ambra Paolini, et al.
International Journal of Molecular Sciences|September 10, 2021
Neoantigen-Specific T-Cell Immune Responses: The Paradigm of NPM1-Mutated Acute Myeloid LeukemiaFabio Forghieri, Giovanni Riva, Ivana Lagreca, et al.
Blood|December 9, 2016
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitorsPatrizia Comoli, Sabrina Basso, Giovanni Riva, et al.
Pageof 5